Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting

Thromb Haemost. 2009 Jan;101(1):23-30.
No abstract available

MeSH terms

  • Angioplasty, Balloon, Coronary* / adverse effects
  • Angioplasty, Balloon, Coronary* / instrumentation
  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Clopidogrel
  • Drug-Eluting Stents
  • Hemorrhage / chemically induced
  • Humans
  • Patient Selection
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Function Tests
  • Practice Guidelines as Topic
  • Prosthesis Design
  • Risk Assessment
  • Stents*
  • Thrombelastography
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin